Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection - Ascher-Svanum, Haya (Eli Lilly and Company, Indianapolis) ; Novick, Diego (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ; Haro Abad, Josep Maria (Institut de Recerca Sant Joan de Déu) ; Bertsch, Jordan (Institut de Recerca Sant Joan de Déu) ; McDonnell, David (Eli Lilly and Company, Indianapolis) ; Detke, Holland (Eli Lilly and Company, Indianapolis)
 
Comments (0) | Reviews (0)
Be the first to review this document.

Add review

Rate this article:
Give a title to your review:
Write your review:
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.